Escalating Clopidogrel by Involving a Genetic Strategy - Thrombolysis In Myocardial Infarction 56 (ELEVATE-TIMI56)
This study is ongoing, but not recruiting participants.
Sponsor:
The TIMI Study Group
Collaborators:
Bristol-Myers Squibb
Sanofi
Information provided by:
The TIMI Study Group
ClinicalTrials.gov Identifier:
NCT01235351
First received: November 2, 2010
Last updated: October 4, 2011
Last verified: October 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | October 2011 (Final data collection date for primary outcome measure) |
No publications provided by The TIMI Study Group
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):